Maxigen Biotech Inc (1783) — Financial Flexibility Index
Maxigen Biotech Inc (1783) has a Financial Flexibility Index of 0.25x as of March 2026. Free cash flow of NT$90.31 Million (operating CF NT$79.84 Million minus capex NT$10.47 Million) represents 0% of total liabilities (NT$364.27 Million). Check 1783 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Maxigen Biotech Inc Financial Flexibility Index (2009–2025)
Historical Financial Flexibility Index trend for Maxigen Biotech Inc across 17 annual periods. See working capital position of Maxigen Biotech Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Maxigen Biotech Inc (2009–2025)
Year-by-year free cash flow to debt coverage for Maxigen Biotech Inc. For the full company profile including market capitalisation, see Maxigen Biotech Inc (1783) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.05x | NT$372.85 Million | NT$290.22 Million | NT$355.54 Million | ▼ -34.1% |
| 2024 | 1.59x | NT$329.99 Million | NT$298.22 Million | NT$207.36 Million | ▲ +8.4% |
| 2023 | 1.47x | NT$193.64 Million | NT$171.20 Million | NT$131.88 Million | ▼ -21.0% |
| 2022 | 1.86x | NT$282.78 Million | NT$268.34 Million | NT$152.07 Million | ▲ +72.6% |
| 2021 | 1.08x | NT$133.04 Million | NT$117.59 Million | NT$123.47 Million | ▲ +21.0% |
| 2020 | 0.89x | NT$85.73 Million | NT$74.39 Million | NT$96.24 Million | ▲ +151.9% |
| 2019 | 0.35x | NT$118.16 Million | NT$94.42 Million | NT$334.17 Million | ▼ -45.8% |
| 2018 | 0.65x | NT$190.81 Million | NT$170.58 Million | NT$292.48 Million | ▲ +186.0% |
| 2017 | 0.23x | NT$70.18 Million | NT$41.18 Million | NT$307.73 Million | ▼ -32.9% |
| 2016 | 0.34x | NT$107.43 Million | NT$34.72 Million | NT$316.04 Million | ▲ +561.4% |
| 2015 | 0.05x | NT$17.39 Million | NT$-109.85 Million | NT$338.38 Million | ▼ -94.0% |
| 2014 | 0.85x | NT$116.53 Million | NT$-14.45 Million | NT$136.65 Million | ▲ +201.5% |
| 2013 | 0.28x | NT$35.65 Million | NT$-22.34 Million | NT$126.04 Million | ▲ +42.9% |
| 2012 | 0.20x | NT$23.77 Million | NT$17.53 Million | NT$120.10 Million | ▼ -62.4% |
| 2011 | 0.53x | NT$61.83 Million | NT$-76.64 Million | NT$117.40 Million | ▲ +268.1% |
| 2010 | -0.31x | NT$-10.76 Million | NT$-16.76 Million | NT$34.37 Million | ▼ -135.5% |
| 2009 | 0.88x | NT$26.89 Million | NT$19.27 Million | NT$30.51 Million | — |